Quick Answer
Sensus Healthcare, Inc. reported Diluted EPS of $0.47 per share (loss) for fiscal year 2025.
Sensus Healthcare, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.47 | -214.6% |
| 2024 | $0.41 | +1266.7% |
| 2023 | $0.03 | -97.9% |
| 2022 | $1.46 | +484.0% |
| 2021 | $0.25 | +159.5% |
| 2020 | -$0.42 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.06 | -185.7% | +0.0% |
| June 30, 2025 | -$0.06 | -160.0% | +62.5% |
| March 31, 2025 | -$0.16 | -214.3% | -328.6% |
| September 30, 2024 | $0.07 | +177.8% | -30.0% |
| June 30, 2024 | $0.10 | +600.0% | -28.6% |
| March 31, 2024 | $0.14 | +216.7% | +255.6% |
| September 30, 2023 | -$0.09 | -181.8% | -350.0% |
| June 30, 2023 | -$0.02 | -109.5% | +83.3% |
- Sensus Healthcare, Inc. showed a decrease of -214.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Sensus Healthcare, Inc.’s diluted eps has declined by 11.9% (from $0.42 per share (loss) to $0.47 per share (loss)).
- The most recent figure is from Sensus Healthcare, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: